For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...
A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...
An albuterol nebulizer relieves muscle tightening in the airways to help a person breathe. The nebulizer turns liquid medication into a mist, helping it reach the lungs faster. Generally, nebulizers ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...
The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...
The therapies to treat chronic obstructive pulmonary disease (COPD) include devices with instructions for use, which are far more complicated than simply smoking a cigarette. Chronic obstructive ...
Sunovion Pharmaceuticals Inc. moved its nebulized long-acting muscarinic antagonist (LAMA) into phase III development by opening the final two studies in a pivotal program that will collectively ...
Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback